An initiative spearheaded by Genome Canada and the Canadian Institute of Health Research to sequence childhood disease cohorts is highlighting the ethical challenges of using sequencing to study disease in patients. The $C4.5 million project has two arms — one that will use whole-genome sequencing to study childhood cancers and metastatic tumors, and another that will use exome sequencing to study rare Mendelian diseases in children.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.